Back to Trades
Sullivan Mark
Chief Legal OfficerCIK 0001331843
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2025–2026
Sullivan Mark, Chief Legal Officer, has filed 9 SEC reports (2025–2026), all concentrated in Definium Therapeutics, Inc. (DFTX), totaling $1.6M in disclosed volume. Weighing $0 bought versus $1.6M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Sep 29 | DFTX Definium Therapeutics, Inc. | Sullivan Mark | Chief Legal Officer | Sell | $513.8K |
| Sep 14 | DFTX Definium Therapeutics, Inc. | Sullivan Mark | Insider | Grant | $0 |
| Aug 12 | DFTX Definium Therapeutics, Inc. | Sullivan Mark | Insider | Grant | $0 |
| Jun 26 | DFTX Definium Therapeutics, Inc. | Sullivan Mark | Insider | Sell | $585.8K |
| Jun 22 | DFTX Definium Therapeutics, Inc. | Sullivan Mark | Insider | Grant | $0 |
| Mar 26 | DFTX Definium Therapeutics, Inc. | Sullivan Mark | Insider | Sell | $197.7K |
| Feb 5 | DFTX Definium Therapeutics, Inc. | Sullivan Mark | Insider | Grant | $0 |
| Dec 29 | MNMD Mind Medicine (MindMed) Inc. | Sullivan Mark | Insider | Sell | $148.2K |
| Sep 26 | MNMD Mind Medicine (MindMed) Inc. | Sullivan Mark | Insider | Sell | $110.2K |
9 filings